Bruker Corporation
BRKR
$45.69
$0.711.58%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 823.40M | 977.20M | 860.50M | 797.40M | 801.40M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 823.40M | 977.20M | 860.50M | 797.40M | 801.40M |
| Cost of Revenue | 428.20M | 510.40M | 446.30M | 432.30M | 405.10M |
| Gross Profit | 395.20M | 466.80M | 414.20M | 365.10M | 396.30M |
| SG&A Expenses | 242.20M | 244.20M | 242.50M | 231.40M | 226.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 800.00K | 58.70M | -38.10M | 4.70M | 3.20M |
| Total Operating Expenses | 772.50M | 912.90M | 749.00M | 768.60M | 731.40M |
| Operating Income | 50.90M | 64.30M | 111.50M | 28.80M | 70.00M |
| Income Before Tax | 18.20M | 67.00M | -72.60M | 1.10M | 25.50M |
| Income Tax Expenses | 2.50M | 37.80M | -14.10M | -3.10M | 8.70M |
| Earnings from Continuing Operations | 15.70M | 29.20M | -58.50M | 4.20M | 16.80M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.30M | -3.20M | -1.10M | 3.40M | 600.00K |
| Net Income | 14.40M | 26.00M | -59.60M | 7.60M | 17.40M |
| EBIT | 50.90M | 64.30M | 111.50M | 28.80M | 70.00M |
| EBITDA | 109.20M | 122.40M | 167.20M | 84.90M | 120.40M |
| EPS Basic | 0.02 | 0.10 | -0.41 | 0.05 | 0.11 |
| Normalized Basic EPS | 0.19 | 0.20 | 0.43 | 0.10 | 0.27 |
| EPS Diluted | 0.02 | 0.10 | -0.41 | 0.05 | 0.11 |
| Normalized Diluted EPS | 0.19 | 0.20 | 0.43 | 0.10 | 0.27 |
| Average Basic Shares Outstanding | 152.20M | 152.00M | 151.80M | 151.60M | 151.60M |
| Average Diluted Shares Outstanding | 152.70M | 152.50M | 151.80M | 151.70M | 151.90M |
| Dividend Per Share | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| Payout Ratio | 129.17% | 67.69% | 0.00% | 100.00% | 44.25% |